These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34612079)

  • 61. Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: An Analysis of the Beijing Pharmacovigilance Database.
    Wang T; Ma X; Xing Y; Sun S; Zhang H; Stürmer T; Wang B; Li X; Tang H; Jiao L; Zhai S
    Int Arch Allergy Immunol; 2017; 173(1):51-60. PubMed ID: 28505618
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.
    Rodríguez Del Río P; Vidal C; Just J; Tabar AI; Sanchez-Machin I; Eberle P; Borja J; Bubel P; Pfaar O; Demoly P; Calderón MA
    Pediatr Allergy Immunol; 2017 Feb; 28(1):60-70. PubMed ID: 27637414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anaphylaxis in the allergist's office: preparing your office and staff for medical emergencies.
    Wallace DV
    Allergy Asthma Proc; 2013; 34(2):120-31. PubMed ID: 23484886
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):426-431.e1. PubMed ID: 22018614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    J Allergy Clin Immunol Pract; 2014; 2(2):161-7. PubMed ID: 24607043
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multicenter study of emergency department visits for food allergies.
    Clark S; Bock SA; Gaeta TJ; Brenner BE; Cydulka RK; Camargo CA;
    J Allergy Clin Immunol; 2004 Feb; 113(2):347-52. PubMed ID: 14767453
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.
    Chu DK; Wood RA; French S; Fiocchi A; Jordana M; Waserman S; Brożek JL; Schünemann HJ
    Lancet; 2019 Jun; 393(10187):2222-2232. PubMed ID: 31030987
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The safety and efficacy of ALLERVAX CAT in cat allergic patients.
    Maguire P; Nicodemus C; Robinson D; Aaronson D; Umetsu DT
    Clin Immunol; 1999 Dec; 93(3):222-31. PubMed ID: 10600332
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anaphylaxis in Children and Adolescents.
    Poowuttikul P; Seth D
    Pediatr Clin North Am; 2019 Oct; 66(5):995-1005. PubMed ID: 31466687
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Approach to Patients with Stinging Insect Allergy.
    Abrams EM; Golden DBK
    Med Clin North Am; 2020 Jan; 104(1):129-143. PubMed ID: 31757231
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?
    Lang DM
    Curr Allergy Asthma Rep; 2008 Mar; 8(1):37-44. PubMed ID: 18377773
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Canadian allergists' and nonallergists' perception of epinephrine use and vaccination of persons with egg allergy.
    Desjardins M; Clarke A; Alizadehfar R; Grenier D; Eisman H; Carr S; Vander Leek TK; Teperman L; Higgins N; Joseph L; Shand G; Ben-Shoshan M
    J Allergy Clin Immunol Pract; 2013; 1(3):289-94. PubMed ID: 24565487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictors of Repeat Epinephrine Administration for Emergency Department Patients with Anaphylaxis.
    Campbell RL; Bashore CJ; Lee S; Bellamkonda VR; Li JT; Hagan JB; Lohse CM; Bellolio MF
    J Allergy Clin Immunol Pract; 2015; 3(4):576-84. PubMed ID: 26032476
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical Characteristics of Allergy to Hymenoptera Stings.
    Visitsunthorn N; Kijmassuwan T; Visitsunthorn K; Pacharn P; Jirapongsananuruk O
    Pediatr Emerg Care; 2019 Sep; 35(9):600-604. PubMed ID: 28614101
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Managing anaphylaxis in the office setting.
    Cingi C; Wallace D; Bayar Muluk N; Ebisawa M; Castells M; Şahin E; Altıntoprak N
    Am J Rhinol Allergy; 2016 Jul; 30(4):118-23. PubMed ID: 27456586
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Anaphylaxis: facts and fallacies].
    Brand PL
    Ned Tijdschr Geneeskd; 2007 Mar; 151(10):574-7. PubMed ID: 17402646
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety of epinephrine for anaphylaxis in the emergency setting.
    Wood JP; Traub SJ; Lipinski C
    World J Emerg Med; 2013; 4(4):245-51. PubMed ID: 25215127
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Indication for adrenalin autoinjector after anaphylaxis].
    Malling HJ; Hansen KS; Mosbech H
    Ugeskr Laeger; 2012 Jun; 174(25):1741-3. PubMed ID: 22713223
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
    Malling HJ
    Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Walnut oral immunotherapy for desensitisation of walnut and additional tree nut allergies (Nut CRACKER): a single-centre, prospective cohort study.
    Elizur A; Appel MY; Nachshon L; Levy MB; Epstein-Rigbi N; Pontoppidan B; Lidholm J; Goldberg MR
    Lancet Child Adolesc Health; 2019 May; 3(5):312-321. PubMed ID: 30926371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.